glutathione rapta c Tumor-targeted oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Organoruthenium Prodrugs as a New
Organoruthenium Prodrugs as a New Class of Cholinesterase and GlutathioneSTransferase Inhibitors Ristovski 2018 ChemMedChem Wiley Online Library The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium Based Complexes Anticancer activity of RAPTA EA1 in triple negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib ScienceDirect Anti cancer organoruthenium( ii ) complexes and their interactions with cysteine and its analogues. A mass spectrometric study Dalton Transactions (RSC Publishing) DOI:10.1039 C8DT04350G
Pay in 4 interest-free payments of $6.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



